Your browser doesn't support javascript.
loading
Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen.
Artamonov, Mikhail Yu; LeBaron, Tyler W; Pyatakovich, Felix A; Minenko, Inessa A.
Afiliação
  • Artamonov MY; MJA Research and Development, Inc., East Stroudsburg, PA 18301, USA.
  • LeBaron TW; Department of Kinesiology and Outdoor Recreation, Southern Utah University, Cedar City, UT 84720, USA.
  • Pyatakovich FA; Molecular Hydrogen Institute, Enoch, UT 84721, USA.
  • Minenko IA; MJA Research and Development, Inc., East Stroudsburg, PA 18301, USA.
Pharmaceuticals (Basel) ; 17(4)2024 Apr 07.
Article em En | MEDLINE | ID: mdl-38675429
ABSTRACT
Stem cell therapy has emerged as a promising avenue for regenerative medicine, offering the potential to treat a wide range of debilitating diseases and injuries. Among the various types of stem cells, mesenchymal stem cells (MSCs) have garnered significant attention due to their unique properties and therapeutic potential. In recent years, researchers have been exploring novel approaches to enhance the effectiveness of MSC-based therapies. One such approach that has gained traction is the priming of MSCs with molecular hydrogen (H2). This article delves into the fascinating world of mesenchymal stem cell priming with molecular hydrogen and the potential benefits it holds for regenerative medicine.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos